Ipamorelin — 5mg
Product Overview
Ipamorelin is a synthetic pentapeptide studied as an agonist of the growth-hormone secretagogue receptor, also known as the ghrelin receptor.
Research Background
Early comparative studies examined the selectivity of ipamorelin-induced growth-hormone release relative to other secretagogues and growth-hormone-releasing hormone. It is used as a model for receptor selectivity and pituitary signalling.
Current Areas of Investigation
Research includes receptor activation, endocrine pulse signalling, selectivity among pituitary hormones and ghrelin-receptor effects in preclinical systems.
In Plain Language
Researchers use ipamorelin to study how the ghrelin receptor can signal the pituitary gland to release growth hormone and how selective that response is compared with other secretagogues. Early studies found a more selective hormone-release profile than several older growth-hormone-releasing peptides.
In plain terms, the research focuses on whether ipamorelin can trigger growth-hormone pulses while having less effect on other pituitary or stress hormones. Researchers examine downstream IGF-1 signalling, body-composition pathways, tissue recovery and gastrointestinal movement in controlled models.
Product Specifications
- Catalogue No.: IP2
- Vial Size: 5mg
Quality & Documentation
Lot-specific product documentation and Certificate of Analysis (COA) information may be available through AURAPEP where applicable.
Research Use Only
RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION. Supplied strictly for laboratory, analytical and research purposes. Not intended for self-administration or to diagnose, treat, cure or prevent any disease.
